Deferred Tax Assets, Operating Loss Carryforwards in USD of Vitro Biopharma, Inc. from Q3 2022 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Vitro Biopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q3 2022 to Q3 2024.
- Vitro Biopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Oct 2024 was $4.56M, a 48.4% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)